This public procurement record has 2 releases in its history.

Award

19 Mar 2025 at 09:15

Tender

01 Nov 2024 at 13:49

Summary of the contracting process

The Common Services Agency, also known as NHS National Services Scotland (NSS), is seeking suppliers for the "NP47924 Cytokine Modulators" contracting process within the pharmaceutical products industry. The procurement stage is currently active, focusing on the supply of cytokine modulators across several lots, including Etanercept, Infliximab IV, Infliximab SC, and various concentrations of Methotrexate syringes and pens. This open procedure aims to establish multiple framework agreements, with key lots such as Infliximab IV and Etanercept targeted for multi-supplier frameworks. The procurement process will conclude on 2nd December 2024, and the framework agreement will include potential extension options up to 24 months.

This tender provides significant business opportunities, particularly for pharmaceutical suppliers capable of meeting NHS Scotland's rigorous standards, including valid UK marketing authorisation, BS EN ISO 9001 certification, and adherence to MHRA best practice guidance. With an emphasis on quality and price, the framework supports both large and specialised pharmaceutical providers. Additionally, the initiative promotes community benefits, urging suppliers to engage in community development through the NHS Scotland Community Benefits Gateway, making it suitable for companies looking to enhance their social value contributions while securing long-term contracts in the healthcare sector.

How relevant is this notice?

Notice Title

NP47924 Cytokine Modulators

Notice Description

Supply of Cytokine Modulators to NHS Scotland.

Lot Information

Etanercept

Supply of Etanercept to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Infliximab IV

Supply of Infliximab IV to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of five (5) Framework Participants.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Infliximab SC

Supply of Infliximab SC to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per product line.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Methotrexate syringes (25mg/1 ml concentration)

Supply of Methotrexate syringes (25mg/1 ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Methotrexate pens (25mg/1ml concentration)

Supply of Methotrexate pens (25mg/1ml concentration)to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Methotrexate pens (50mg/1 ml concentration)

Supply of Methotrexate pens (50mg/1 ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Methotrexate syringes (50mg/1ml concentration)

Supply of Methotrexate syringes (50mg/1ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-04b34f
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/010054-2025
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
Not specified
Lots Value
£22,963,164 £10M-£100M
Awards Value
Not specified
Contracts Value
£55,943,000 £10M-£100M

Notice Dates

Publication Date
19 Mar 20251 years ago
Submission Deadline
2 Dec 2024Expired
Future Notice Date
Not specified
Award Date
29 Jan 20251 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Postcode Area
Edinburgh
Country
Scotland

Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland

Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Supplier Information

Number of Suppliers
9
Supplier Names

Accord Healthcare Ltd

Biogen Idec Ltd

Celltrion Healthcare United Kingdom Limited

Janssen Cilag Limited

Nordic Pharma Ltd

Pfizer Ltd

Sandoz

Sandoz Ltd

medac Pharma LLP

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...